BofA/Merrill Lynch Starts Genomic Health Inc. (GHDX) at Buy
Tweet
Share
E-mailGet Alerts GHDX Hot Sheet
Price: $63.44 --0%
Rating Summary:
3 Buy, 15 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 20
Rating Summary:
3 Buy, 15 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 20
Join SI Premium – FREE
BofA/Merrill Lynch initiates coverage on Genomic Health Inc. (NASDAQ: GHDX) with a Buy. PT $44.00.
For an analyst ratings summary and ratings history on Genomic Health Inc. click here. For more ratings news on Genomic Health Inc. click here.
Shares of Genomic Health Inc. closed at $34.30 yesterday.
For an analyst ratings summary and ratings history on Genomic Health Inc. click here. For more ratings news on Genomic Health Inc. click here.
Shares of Genomic Health Inc. closed at $34.30 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Enovix Corporation (ENVX) PT Lowered to $5 at BofA Securities
- BofA Securities Resumes American Eagle Outfitters (AEO) at Underperform
- BofA launches AI tracker as Claude leads intelligence rankings
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
